BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38795847)

  • 1. Multi-targeted effects of D-carvone against Non-Small Cell Lung Cancer (NSCLC): A network pharmacology-based study.
    Irshad R; Batool F; Raj N; Karim S; Alkreathy HM; Manzoor N; Husain M
    Toxicol Appl Pharmacol; 2024 Jun; 487():116978. PubMed ID: 38795847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the mechanism of action of Isobavachalcone induced autophagy and apoptosis in non-small cell lung cancer by network pharmacology and experimental validation methods.
    Wang L; Wang Z; Ni Y; Wang X; Zhang T; Hu M; Lian C; Wang X; Zhang J
    Gene; 2024 Aug; 918():148474. PubMed ID: 38670393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. On non-small cell lung cancer based on a network pharmacology approach and experimental validation.
    Zhang Y; Yao Y; Fu Y; Yuan Z; Wu X; Wang T; Hong Z; Yang Y; Wu H
    J Ethnopharmacol; 2021 Oct; 278():114267. PubMed ID: 34087401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
    Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated network pharmacology and experimental analysis unveil multi-targeted effect of 18α- glycyrrhetinic acid against non-small cell lung cancer.
    Irshad R; Raj N; Gabr GA; Manzoor N; Husain M
    Front Pharmacol; 2022; 13():1018974. PubMed ID: 36313358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation.
    Liu X; Ren Y; Qin S; Yang Z
    BMC Complement Med Ther; 2024 May; 24(1):202. PubMed ID: 38783288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the Active Compounds and Significant Pathways of Artemisia Annua in the Treatment of Non-Small Cell Lung Carcinoma based on Network Pharmacology.
    Zhang SQ; Xu HB; Zhang SJ; Li XY
    Med Sci Monit; 2020 May; 26():e923624. PubMed ID: 32474568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking.
    Xie RF; Song ZY; Xu-Shao LY; Huang JG; Zhao T; Yang Z
    Medicine (Baltimore); 2022 Dec; 101(52):e32555. PubMed ID: 36596057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blaps rynchopetera affects proliferation, migration, and invasion of non-small cell lung cancer: a study based on network pharmacology and in vivo and in vitro experiments].
    Li XY; Ma K; Yan JN; You FC; Ma L
    Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3576-3588. PubMed ID: 37474991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating network pharmacology and experimental verification to investigate the pharmacological mechanisms of Buzhong Yiqi decoction in the treatment of non-small cell lung cancer.
    Zeng P; Wang F; Zhang J; Ur Rashid H; Li X; Zhang P; Luo Y; Wu X
    Chem Biol Drug Des; 2024 Jan; 103(1):e14414. PubMed ID: 38230796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network pharmacology analysis, molecular docking integrated experimental verification reveal β-sitosterol as the active anti-NSCLC ingredient of Polygonatum cyrtonema Hua by suppression of PI3K/Akt/HIF-1α signaling pathway.
    Cao W; Yuan F; Liu T; Yin R
    J Ethnopharmacol; 2024 Jun; 328():117900. PubMed ID: 38432577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating network pharmacology and experimental models to investigate the mechanisms of dihydroartemisinin in preventing NSCLC progression via mTOR/HIF-1α signaling.
    Li Y; Xiao X; Wang H; Zhou Q; Jin Z; Zhang Y; Wang Y; Yue F; Zhou S; Yang J
    Eur J Pharmacol; 2021 Oct; 909():174411. PubMed ID: 34390710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer.
    Yuan C; Wang MH; Wang F; Chen PY; Ke XG; Yu B; Yang YF; You PT; Wu HZ
    Life Sci; 2021 Apr; 270():119105. PubMed ID: 33497736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evodiamine suppresses Notch3 signaling in lung tumorigenesis via direct binding to γ-secretases.
    Yang X; Zhang Y; Huang Y; Wang Y; Qi X; Su T; Lu L
    Phytomedicine; 2020 Mar; 68():153176. PubMed ID: 32045841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer.
    Lee K; Choi YJ; Lim HI; Cho KJ; Kang N; Ko SG
    BMC Complement Med Ther; 2024 Feb; 24(1):70. PubMed ID: 38303001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of Rhubarb in the treatment of non-small cell lung cancer based on network pharmacology and molecular docking technology.
    Tan YR; Lu Y
    Mol Divers; 2023 Jun; 27(3):1437-1457. PubMed ID: 35933455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential mechanism of Chai Gui Zexie Decoction for NSCLC treatment assessed using network pharmacology, bioinformatics, and molecular docking: An observational study.
    Lin M; Zhao A; Chen B
    Medicine (Baltimore); 2024 May; 103(20):e38204. PubMed ID: 38758858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway.
    You J; Cheng J; Yu B; Duan C; Peng J
    Med Sci Monit; 2018 Apr; 24():2126-2133. PubMed ID: 29632297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncovering the anti-NSCLC effects and mechanisms of gypenosides by metabolomics and network pharmacology analysis.
    Qi YS; Xie JB; Xie P; Duan Y; Ling YQ; Gu YL; Piao XL
    J Ethnopharmacol; 2021 Dec; 281():114506. PubMed ID: 34371113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.